Bank Wants Out Of Drugmaker MannKind's Stock-Drop Suit
Health care specialty bank H.C. Wainwright has asked a California federal court to toss a second amended complaint accusing it of fraudulently inflating the stock of pharmaceutical company MannKind Corp., arguing...To view the full article, register now.
Already a subscriber? Click here to view full article